ArticleCell death & disease2022

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.

Ozlem Yedier-Bayram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.